Closed-Loop Vibrotactile Neuromodulation for Reducing Tremor-Related Propranolol Use

Authors

Soneji, A. A., Agarwal, V.

Abstract

Pathological tremor is a neurological condition that impairs fine motor tasks, affecting 1% of the general population and 4% of the elderly. Tremors arise when muscle micro-oscillations synchronize and phase lock, typically within a 4-12 Hz frequency range. Administering beta-blockers can reduce tremor severity, but doses are hard to personalize, with heavy doses of propranolol correlating with low blood pressure, dizziness, and nausea. In this project, we aimed to model tremor and create a closed-loop control framework to suppress tremor amplitude while minimizing pharmacological dependence. Because side effects constrain the use of pharmacological suppression alone, we investigated noninvasive neuromodulation. We used vibrotactile stimulation (VTS) to disrupt pathological tremor synchronization and reduce oscillatory amplitude. We hypothesized that tremor suppression involving VTS followed a nonmonotonic relationship, tested by determining whether maximum relief requires an adaptable framework. The procedure consisted of constructing a propranolol-reduction simulation by implementing a Hill curve, where we calculated and utilized tremor reduction, heart rate (HR) drop, and blood pressure (BP) drop. We then built a device to capture tremor-related data and create vibration using two linear resonant actuator (LRA) coin motors. We connected it to a microcontroller, where we determined optimal vibration frequencies through a feedback loop. Across 50 trials, VTS alone reduced tremor amplitude by an average of 37.3%, reducing the propranolol dose needed to reach 50% total tremor reduction by 71.9%, lowering the modeled blood pressure drop from 38.1 to 18.9 mmHg. This device demonstrates proof-of-concept for a nonmonotonic tremor-vibration relationship to reduce dependency on propranolol in the treatment of pathological tremor. These propranolol dose-reduction estimates are derived from computational simulation and have not been clinically validated; they are not intended as a recommendation to alter prescribed medication.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 11 Aug 2026.

Stats

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.